» Articles » PMID: 35185448

Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?

Overview
Journal Front Neurosci
Date 2022 Feb 21
PMID 35185448
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, manifests with motor and non-motor symptoms associated with two main pathological hallmarks, including the deterioration of dopaminergic cells and aggregation of alpha-synuclein. Yet, PD is a neurodegenerative process whose origin is uncertain and progression difficult to monitor and predict. Currently, a possibility is that PD may be secondary to long lasting peripheral affectations. In this regard, it has been shown that retinal degeneration is present in PD patients. Although it is unknown if retinal degeneration precedes PD motor symptoms, the possibility exists since degeneration of peripheral organs (e.g., olfaction, gut) have already been proven to antedate PD motor symptoms. In this paper, we explore this possibility by introducing the anatomical and functional relationship of retina and brain and providing an overview of the physiopathological changes of retinal structure and visual function in PD. On the basis of the current status of visual deficits in individuals with PD, we discuss the modalities and pathological mechanism of visual function or morphological changes in the retina and focus on the correlation between visual impairment and some representative structural features with clinical significance. To consider retinal degeneration as a contributor to PD origin and progress is important because PD evolution may be monitored and predicted by retinal studies through state-of-the-art techniques of the retina. It is significant to integrally understand the role of retinal morphological and functional changes in the neurodegenerative process for the diagnosis and therapeutic strategies of PD.

Citing Articles

Artificial intelligence in stroke risk assessment and management via retinal imaging.

Khalafi P, Morsali S, Hamidi S, Ashayeri H, Sobhi N, Pedrammehr S Front Comput Neurosci. 2025; 19:1490603.

PMID: 40034651 PMC: 11872910. DOI: 10.3389/fncom.2025.1490603.


Macular structural integrity estimates are associated with Parkinson's disease genetic risk.

Diaz-Torres S, Lee S, Ogonowski N, Mackey D, Macgregor S, Gharahkhani P Acta Neuropathol Commun. 2024; 12(1):130.

PMID: 39135092 PMC: 11320880. DOI: 10.1186/s40478-024-01841-9.


Transcriptome Study of rd1Mouse Brain and Association with Parkinson's Disease.

Zhou Y, Yang Y, Qi T, Hou Z, Ge Q, Lu Z ACS Omega. 2024; 9(24):25756-25765.

PMID: 38911794 PMC: 11191077. DOI: 10.1021/acsomega.3c09938.


Fractal Phototherapy in Maximizing Retina and Brain Plasticity.

Zueva M, Neroeva N, Zhuravleva A, Bogolepova A, Kotelin V, Fadeev D Adv Neurobiol. 2024; 36:585-637.

PMID: 38468055 DOI: 10.1007/978-3-031-47606-8_31.


The Interplay between Neurotransmitters and Calcium Dynamics in Retinal Synapses during Development, Health, and Disease.

Boff J, Shrestha A, Madireddy S, Viswaprakash N, Santina L, Vaithianathan T Int J Mol Sci. 2024; 25(4).

PMID: 38396913 PMC: 10889697. DOI: 10.3390/ijms25042226.


References
1.
Yavas G, Yilmaz O, Kusbeci T, Ozturk F . The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur J Ophthalmol. 2007; 17(5):812-6. DOI: 10.1177/112067210701700520. View

2.
Onofrj M, Thomas A, Bonanni L . New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins. Expert Rev Neurother. 2007; 7(12):1731-50. DOI: 10.1586/14737175.7.12.1731. View

3.
ODonnell B, Bismark A, Hetrick W, Bodkins M, Vohs J, Shekhar A . Early stage vision in schizophrenia and schizotypal personality disorder. Schizophr Res. 2006; 86(1-3):89-98. DOI: 10.1016/j.schres.2006.05.016. View

4.
Willis G . Intraocular microinjections repair experimental Parkinson's disease. Brain Res. 2008; 1217:119-31. DOI: 10.1016/j.brainres.2008.03.083. View

5.
Lee J, Kim J, Ahn J, Kim H, Jeon B, Kim T . Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease. Mov Disord. 2013; 29(1):61-7. DOI: 10.1002/mds.25543. View